Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

LENZ - LENZ Therapeutics, Inc. Financial... | Finranks

Home

/

LENZ

L

LENZ Therapeutics, Inc. (LENZ)

NMS – Real Time Price. Currency in USD

5.84

+0.63 (12.09%)

Market open: Aug 12, 2026, 10:08 AM EDT

5.55

+0.34 (6.53%)

Previous after-hours: Aug 11, 2026, 7:56 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

19M

0

0

0

Cost of goods sold

-705K

-58K

-15K

-8M

Gross Profit

18M

-58K

-15K

-8M

Operating expenses (excl. COGS)

-110M

-59M

-72M

-97M

Operating Income

-91M

-59M

-72M

-106M

Non-operating income, total

10M

9M

2M

5M

Pretax income

-82M

-50M

-70M

-101M

Equity in earnings

0

0

0

0

Taxes

-502K

-1K

179K

0

Non-controlling/minority interest

0

0

0

0

After tax other income/expense

0

0

0

0

Net income before discontinued operations

-82M

-50M

-70M

-101M

Discontinued operations

0

0

0

0

Net income

-82M

-50M

-70M

-101M

Dilution adjustment

0

0

0

0

Preferred dividends

0

0

0

0

Name

2025

2024

2023

2022

Total assets

306M+42.1%

215M+205.9%

70M-78.1%

322M

Total current assets

301M

212M

67M

275M

Total non-current assets

4M

3M

3M

47M

Total liabilities

22M+92.0%

11M-43.0%

20M-23.1%

26M

Total current liabilities

21M

10M

19M

13M

Total non-current liabilities

350K

814K

1M

13M

Total equity

284M

204M

51M

296M

Total liabilities & shareholders' equities

306M

215M

70M

322M

Total debt

815K-41.0%

1M+319.8%

329K-94.3%

6M

Name

2025

2024

2023

2022

Cash from operating activities

-69M

-59M

-60M

-88M

Cash from investing activities

-76M

-154M

-30M

-242M

Cash from financing activities

150M

199M

81M

597K

Free cash flow

-70M-16.9%

-60M+0.9%

-60M+36.1%

-95M